Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05502289 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Delefilcon A and Verofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of Wear
A NA study of Ocular Physiology, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 6
- Study locations
NCT05502289: Completed NA study of Ocular Physiology, sponsored by Johnson & Johnson Vision Care.
NCT05502289 is a NA study of Ocular Physiology that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05502289, a NA study of Ocular Physiology, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a bilateral-wear, dispensing, randomized, controlled, double-masked, 2-sequence × 2-period crossover study to evaluate ocular physiology following contact lens wear.
Primary Outcome
Slit Lamp Findings (SLF) were assessed using a biomicroscope and was graded using the FDA grading scale (Grade: 0, 1,2, 3 and 4) with grade 0 represents the absence of findings and 1 to 4 representing successively worse findings (i.e. Grade 1 = trace, Grade 2 = Mild, Grade 3 = moderate and Grade 4 = severe). This was performed on each subject eye at every study visit (baseline, unscheduled visits and 1-week follow-up), however data collected at the 1-week follow-up is the primary endpoint. The d
Conditions Studied
Interventions
- DEVICE TEST LENS
- DEVICE CONTROL LENS
Study Locations (6)
Florida
- Sabal Eye Care - Longwood
- Maitland Vision Center - North Orlando Ave - Maitland
New York
- Sacco Eye Group - Vestal
Ohio
- Professional Vision Care Inc. - Westerville - Westerville
Tennessee
- Optometry Group, LLC - Memphis
Virginia
- Botetourt Eyecare, LLC - Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2022-08-19 |
| Est. Completion | 2022-10-17 |
| Phase | NA |
What the finished NCT05502289 record still lists
NCT05502289 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Ocular Physiology appearing as the primary indexed condition, and to 2 interventions - of which TEST LENS is the first listed.
NCT05502289 lists 6 locations in 5 states (Florida, New York, Ohio).
Frequently Asked Questions
What is clinical trial NCT05502289 about?
NCT05502289 is a clinical study titled "Clinical Evaluation of Delefilcon A and Verofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of Wear". This is a bilateral-wear, dispensing, randomized, controlled, double-masked, 2-sequence × 2-period crossover study to evaluate ocular physiology following contact lens wear.
What is the current status of trial NCT05502289?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2022-08-19. Estimated completion is 2022-10-17.
What conditions does trial NCT05502289 study?
This clinical trial studies the following conditions: Ocular Physiology.
What interventions are being tested in trial NCT05502289?
The interventions under investigation include: TEST LENS (DEVICE), CONTROL LENS (DEVICE).
Who is sponsoring clinical trial NCT05502289?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05502289 being conducted?
This trial has 6 study locations across Florida, New York, Ohio, Tennessee, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ocular Physiology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05502289's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI